These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33032865)

  • 1. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
    Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
    Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
    Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
    Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival.
    Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Scharll Y; Ianetti-Hackl C; Bale R
    Cardiovasc Intervent Radiol; 2021 Aug; 44(8):1184-1193. PubMed ID: 33825059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases.
    Bale R; Widmann G; Schullian P; Haidu M; Pall G; Klaus A; Weiss H; Biebl M; Margreiter R
    Eur Radiol; 2012 Apr; 22(4):930-7. PubMed ID: 22071776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
    Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
    Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
    Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical analysis of ultrasound-guided radiofrequency ablation for recurrent colorectal liver metastases after hepatectomy.
    Fan XX; Lv SY; Zhang MW; Dai XY; Zhao JP; Mao DF; Zhang Y
    World J Surg Oncol; 2020 Apr; 18(1):76. PubMed ID: 32312256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiofrequency ablation of tumors at the hepatic venous confluence.
    Schullian P; Johnston E; Laimer G; Scharll Y; Putzer D; Eberle G; Kolbitsch C; Amann A; Stättner S; Bale R
    HPB (Oxford); 2022 Jul; 24(7):1044-1054. PubMed ID: 34887174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiofrequency ablation of subcardiac hepatocellular carcinoma: a case-control study.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Int J Hyperthermia; 2019; 36(1):876-885. PubMed ID: 31462110
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation of Recurrent Colorectal Cancer Liver Metastases after Hepatectomy.
    Valls C; Ramos E; Leiva D; Ruiz S; Martinez L; Rafecas A
    Scand J Surg; 2015 Sep; 104(3):169-75. PubMed ID: 25332220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency Ablation to Improve Survival After Conversion Chemotherapy for Colorectal Liver Metastases.
    Nielsen K; Scheffer HJ; Volders JH; van der Vorst MJ; van Tilborg AA; Comans EF; de Lange-de Klerk ES; Sietses C; Meijer S; Meijerink MR; van den Tol MP
    World J Surg; 2016 Aug; 40(8):1951-8. PubMed ID: 27220509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiofrequency ablation of a variety of liver masses in children.
    Hetzer B; Vogel GF; Entenmann A; Heil M; Schullian P; Putzer D; Meister B; Crazzolara R; Kropshofer G; Salvador C; Straub S; Karall D; Niederwanger C; Cortina G; Janecke A; Freund-Unsinn K; Maurer K; Schweigmann G; Oberhuber G; Renz O; Schneeberger S; Müller T; Bale R
    Int J Hyperthermia; 2020; 37(1):1074-1081. PubMed ID: 32954876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy.
    van der Pool AE; Lalmahomed ZS; de Wilt JH; Eggermont AM; Ijzermans JM; Verhoef C
    J Gastrointest Surg; 2009 May; 13(5):890-5. PubMed ID: 19132450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
    Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
    World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Radiofrequency Ablation for Metastatic Melanoma to the Liver.
    Bale R; Schullian P; Schmuth M; Widmann G; Jaschke W; Weinlich G
    Cardiovasc Intervent Radiol; 2016 Aug; 39(8):1128-35. PubMed ID: 27055850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive local treatment for recurrent intrahepatic cholangiocarcinoma-Stereotactic radiofrequency ablation as a valuable addition to hepatic resection.
    Braunwarth E; Schullian P; Kummann M; Reider S; Putzer D; Primavesi F; Stättner S; Öfner D; Bale R
    PLoS One; 2022; 17(1):e0261136. PubMed ID: 34982804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.